MOLECULAR PHARMACOLOGY

简称 MOL PHARMACOL ·UNITED STATES ·出版周期 Monthly ·年均收录 125 篇

3.0

最新影响因子

4.20%

自引率

较难

投稿难度

一般,3-6周

审稿周期

期刊简介

MOLECULAR PHARMACOLOGY是一本专注于分子药理学领域的学术期刊，ISSN号为0026-895X，由美国药理学会（American Society for Pharmacology and Experimental Therapeutics, ASPET）出版，出版地为美国，出版周期为月刊。该杂志的影响因子根据年份有所不同，近年保持在3-4左右，属于SCI收录期刊，中科院分区通常位于医学或药学领域的3区或4区。杂志为非开放获取（非OA）期刊。MOLECULAR PHARMACOLOGY的发文特点侧重于分子水平的药理学研究，涵盖药物作用机制、受体信号传导、药物代谢与转运、基因与蛋白质调控等领域，尤其关注基础研究与临床应用的结合。杂志的质量较高，审稿严格，但作为非OA期刊，可能存在发表周期较长或读者获取受限的风险。总体而言，该杂志是分子药理学领域的重要刊物，适合从事基础药理学研究的学者投稿或阅读。

影响因子趋势

近期发表

Regulation of transient receptor potential ankyrin-1 agonist–induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase 2026-08-28

High potency μ-opioid receptor agonists engage sodium-bound receptor states 2026-08-24

Piezo1 agonists are potent off-target inhibitors of the Kv1.3 channel via gating modification 2026-07-29

Molecular basis for state-dependent drug block of Kv11.1 (human ether-à-go-go-related gene) potassium channels 2026-08-04

Promotion of tumor cell senescence by the antibody–drug conjugate, sacituzumab govitecan 2026-07-21

ZD-4009, a novel B-cell lymphoma 9 inhibitor, is associated with ameliorated pulmonary fibrosis and reduced hypoxia-inducible factor 1α–mediated glycolysis and transforming growth factor-β/SMAD signaling 2026-07-24

A conserved conformation-dependent mechanism for the TREK K2P channel inhibitors carvedilol and fluphenazine 2026-09-12

AKAP6β—a conductor in the orchestra of pathological cardiomyocyte gene transcription 2026-07-24

An integrated structural and functional profiling approach uncovers the mechanisms of pregnane X receptor binding and activation by pharmaceutical and environmental compounds 2026-06-24

The molecular geography of cell signaling diseases 2026-08-11